Business
AstraZeneca COVID-19 vaccine: What triggered shutdown of vaccine hope – NEWS.com.au
AstraZeneca COVID-19 vaccine: What triggered shutdown of vaccine hope
A participant in AstraZenecas coronavirus vaccine trial triggered a global shutdown of the promising vaccine after she experienced worrying neurological symptoms.The woman’s symptoms were consistent with transverse myelitis, a serious spinal inflammatory disorder that can cause bladder problems, muscle weakness, pain and at worst, paralysis.
AstraZeneca chief executive Pascal Soriot revealed the woman’s symptoms in a private conference call with investors yesterday, information that was later s…
-
Noosa News24 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
General23 hours agoTyler Wright soaks up Bells Beach return as poor conditions at Rip Curl Pro sees men’s opening round called off
-
General23 hours agoTruck driver charged with causing death by dangerous driving after highway crash
-
Noosa News21 hours agoGyrocopter pilot injured in crash-landing on K’Gari, north of Brisbane